Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1). (Q46902895)
Jump to navigation
Jump to search
scientific article published in September 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1). |
scientific article published in September 2007 |
Statements
1 reference
Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1). (English)
1 reference
Toshiaki Takahashi
1 reference
Hidehiko Ono
1 reference
Yuko Ono
1 reference
Toshihiko Ishimitsu
1 reference
Hiroaki Matsuoka
1 reference
1 September 2007
1 reference
1 reference
48
1 reference
5
1 reference
637-647
1 reference
Identifiers
1 reference
1 reference